The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 20 December 2005, www.theannals.com, DOI 10.1345/aph.1G143.
 The Annals of Pharmacotherapy: Vol. 40, No. 1, pp. 124-127. DOI 10.1345/aph.1G143
© 2006 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow Résumé Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nair, K. V
Right arrow Articles by Saseen, J. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nair, K. V
Right arrow Articles by Saseen, J. J

Las medidas de calidad en cuidado dirigido permiten a los compradores de cuidado de salud distinguir entre planes de salud. Para dislipidemia, las medidas existentes (siglas para Health Plan Employer Data and Information Set) proveen un retrato limitado de la calidad del cuidado para beneficiarios de planes de salud comerciales. Nueva evidencia (Estudio de Protección del Corazón) y guías de consenso (Programa Nacional de Educación sobre Colesterol) expanden la definición de poblaciones de alto riesgo y hacen énfasis en la farmacoterapia en el manejo de dislipidemia. Creemos que evidencia y estándares más nuevos proveen a los planes médicos mejor oportunidad para evaluar de forma precisa la calidad del cuidado de dislipidemia para sus poblaciones. Proponemos un amplio marco de referencia que provee a los planes médicos guía para el desarrollo de una nueva medida de calidad para dislipidemia que enfoca en la farmacoterapia.

www.theannals.com, DOI 10.1345/aph.1G143



This Article
Right arrow Abstract Freely available
Right arrow Résumé Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nair, K. V
Right arrow Articles by Saseen, J. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nair, K. V
Right arrow Articles by Saseen, J. J

homecopy help contact us subscription past issues search current issue
Copyright © 2006 by Harvey Whitney Books Company.